Skip to main content
. 2023 Jul 13;23:67. doi: 10.1186/s40644-023-00589-0

Table 2.

Relationship between clinicopathologic features and lymph nodes metastases in 90 patients

Parameters Total
(n = 90)
ypN0
(n = 63)
ypN+
(n = 27)
P value
Age (years) 55 (24–82)* 56(27–82) * 55(24–75) * 0.926 a
Sex 0.830 b
Man 68 (75.6%) 48(76.2%) 20(74.1%)
Woman 22 (24.4%) 15(23.8%) 7(25.9%)
Tumor location# 0.777 c
Upper 11(12.2%) 7(11.1%) 4(14.8%)
Middle 51(56.7%) 35(55.6%) 16(59.3%)
Lower 28(31.1%) 21(33.3%) 7(25.9%)
Histological subtype 0.234 c
Nonmucinous adenocarcinoma 82(91.1%) 59(93.7%) 23(85.2%)
Mucinous adenocarcinoma 8(8.9%) 4(6.3%) 4(14.8.%)
Differentiation 0.808 c
Well 1(1.1%) 1(1.6%) 0(0.0%)
Moderate 78(86.7%) 55(87.3%) 23(85.2%)
Poor 11(12.2%) 7(11.1%) 4(14.8%)
ypT stage 0.004 b
ypT0-2 44(48.9%) 37(58.7%) 7(25.9%)
ypT3-4 46(51.1%) 26(41.3%) 20(74.1%)

* Date are medians and ranges in parentheses

# According to the distance from the most caudal border of the rectal tumor to the anal verge on MRI: upper, > 10 cm; middle, 5–10 cm; lower, < 5 cm

a Mann-Whitney U test, bχ2 test, c Fisher’s exact test

yp, post-neoadjuvant treatment pathological feature